PATENT CLAIM ANALYSIS

Application Number: 16039403
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["514", "254010"]

Abstract:
The present invention relates to methods, and pharmaceutical compositions for the treatment of fibrosis. In particular, the present invention relates to a method of treating fibrosis in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one monoacylglycerol lipase (MGL) inhibitor.

Claim (Index 2):
The method of  claim 1  wherein the fibrosis affects at least one organ selected from the group consisting of skin, heart, liver, lung, and kidney.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 95.0
- Lexical Diversity: 1.375
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15512872', '12765103', '13874835', '13963226', '12765048']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7765717503910663
- 35 USC 102 Novelty (BERT): 0.5337649265621075
- Combined Prediction Score: 0.7522910680081705
- Mean Citation Score: 217.865378
- Max Citation Score: 367.95587
- Similarity Product: 340.8981381290632

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test